Who owns Avidity Biosciences Ord?
- Ticker: RNA
- CUSIP Number: 05370a108
Tip: Access positions for across all investors
Analyze quarterly positions in Avidity Biosciences Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Avidity Biosciences Ord stock
Who bought or sold Avidity Biosciences Ord this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
T. Rowe Price Associates | 6.9M | $63M | 4% | Dec 2023 |
|
Cowen And Company | 5.6M | $51M | 0% | Dec 2023 |
|
Vanguard Group | 4.0M | $37M | 1% | Dec 2023 |
|
venBio Select Advisor | 2.5M | $23M | 0% | Dec 2023 |
|
RA Capital Management | 2.5M | $22M | -62% | Dec 2023 |
|
Artisan Partners Limited Partnership | 2.1M | $19M | -2% | Dec 2023 |
|
Dimensional Fund Advisors | 1.5M | $14M | -6% | Dec 2023 |
|
Balyasny Asset Management | 1.2M | $11M | -40% | Dec 2023 |
|
Casdin Capital | 1.2M | $11M | -6% | Dec 2023 |
|
Boxer Capital | 1.1M | $10M | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 968k | $8.8M | 0% | Dec 2023 |
|
Alethea Capital Management | 855k | $7.7M | 0% | Dec 2023 |
|
Logos Global Management | 775k | $7.0M | 100% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 763k | $6.9M | 467% | Dec 2023 |
|
Two Sigma Investments | 668k | $6.0M | 18% | Dec 2023 |
|
5AM Venture Management | 666k | $6.0M | 0% | Dec 2023 |
|
Charles Schwab Investment Management | 546k | $4.9M | 6% | Dec 2023 |
|
Citadel Advisors | 510k | $4.6M | 104% | Dec 2023 |
|
Two Sigma Advisers | 504k | $4.6M | -7% | Dec 2023 |
|
Alliancebernstein | 375k | $3.4M | -29% | Dec 2023 |
|
Goldman Sachs Group | 354k | $3.2M | -26% | Dec 2023 |
|
Millennium Management | 341k | $3.1M | -54% | Dec 2023 |
|
Raymond James & Associates | 296k | $7.5M | 128% | Mar 2024 |
|
Wellington Management Company | 291k | $2.6M | 17% | Dec 2023 |
|
Candriam Luxembourg S.C.A. | 290k | $2.6M | 71% | Dec 2023 |
|
TD Asset Management | 268k | $2.4M | 0% | Dec 2023 |
|
Bank of America Corporation | 261k | $2.4M | -28% | Dec 2023 |
|
Bank of New York Mellon | 248k | $6.3M | -4% | Mar 2024 |
|
Barclays | 198k | $1.8M | 5% | Dec 2023 |
|
Marshall Wace | 198k | $1.8M | 100% | Dec 2023 |
|
UBS Group | 194k | $1.7M | 68% | Dec 2023 |
|
Wells Fargo & Company | 191k | $1.7M | -5% | Dec 2023 |
|
Propel Bio Management | 179k | $1.6M | 100% | Dec 2023 |
|
Mirae Asset Global Investments | 166k | $1.5M | 301% | Dec 2023 |
|
Mutual Of America Capital Management | 149k | $1.4M | 11% | Dec 2023 |
|
GSA Capital Partners | 144k | $1.3M | -58% | Dec 2023 |
|
Schonfeld Strategic Advisors | 130k | $1.2M | 2% | Dec 2023 |
|
Standard Life Aberdeen | 129k | $1.2M | 100% | Dec 2023 |
|
Simplify Asset Management | 125k | $1.1M | 0% | Dec 2023 |
|
Raymond James Financial Services Advisors | 120k | $3.1M | 38% | Mar 2024 |
|
Swiss National Bank | 117k | $1.1M | -6% | Dec 2023 |
|
State of Wisconsin Investment Board | 115k | $1.0M | 104% | Dec 2023 |
|
Rhumbline Advisers | 115k | $1.0M | 4% | Dec 2023 |
|
New York State Common Retirement Fund | 105k | $950k | 0% | Dec 2023 |
|
PDT Partners | 92k | $829k | 100% | Dec 2023 |
|
Ubs Global Asset Management Americas | 91k | $825k | 0% | Dec 2023 |
|
Citigroup | 86k | $770k | -40% | Dec 2023 |
|
Hennion & Walsh Asset Management | 73k | $1.9M | 2% | Mar 2024 |
|
Jump Financial | 71k | $639k | -36% | Dec 2023 |
|
Jane Street | 70k | $636k | -59% | Dec 2023 |
|
Trexquant Investment | 70k | $632k | -56% | Dec 2023 |
|
Squarepoint Ops | 63k | $570k | -60% | Dec 2023 |
|
Us Bancorp | 62k | $561k | 2% | Dec 2023 |
|
DekaBank Deutsche Girozentrale | 60k | $1.5M | 0% | Mar 2024 |
|
Steward Partners Investment Advisory | 59k | $534k | 203% | Dec 2023 |
|
Legal & General Group | 59k | $533k | 0% | Dec 2023 |
|
Thomas Stevens, CFA" | 57k | $1.5M | -5% | Mar 2024 |
|
Dynamic Technology Lab Private | 53k | $478k | 114% | Dec 2023 |
|
ALPS Advisors | 51k | $459k | -7% | Dec 2023 |
|
Credit Suisse | 50k | $456k | -10% | Dec 2023 |
|
Mirador Capital Partners | 47k | $1.2M | -10% | Mar 2024 |
|
SG Americas Securities | 42k | $377k | 100% | Dec 2023 |
|
D. E. Shaw & Co | 42k | $375k | -73% | Dec 2023 |
|
Mitsubishi UFJ Asset Management | 41k | $394k | 61% | Dec 2023 |
|
MetLife Investment Advisors | 37k | $338k | 0% | Dec 2023 |
|
American International | 37k | $333k | 4% | Dec 2023 |
|
Harbor Capital Advisors | 32k | $293k | 8% | Dec 2023 |
|
J.w. Cole Advisors | 31k | $283k | 100% | Dec 2023 |
|
Corton Capital | 30k | $269k | 19% | Dec 2023 |
|
Nwam | 29k | $265k | -18% | Dec 2023 |
|
Henderson Group | 26k | $236k | 0% | Dec 2023 |
|
Royal Bank of Canada | 24k | $218k | 98% | Dec 2023 |
|
Quest Partners | 23k | $211k | 100% | Dec 2023 |
|
Hrt Financial | 22k | $202k | -82% | Dec 2023 |
|
Florida State Board of Administration | 20k | $183k | 0% | Dec 2023 |
|
Principal Financial Group | 20k | $176k | -7% | Dec 2023 |
|
Deerfield Management Company | 19k | $169k | 100% | Dec 2023 |
|
Hsbc Holdings | 19k | $169k | 45% | Dec 2023 |
|
AtonRa Partners | 17k | $152k | -11% | Dec 2023 |
|
Arizona State Retirement System | 17k | $150k | 3% | Dec 2023 |
|
Zurcher Kantonalbank | 15k | $383k | 31% | Mar 2024 |
|
Two Sigma Securities | 14k | $127k | 100% | Dec 2023 |
|
Teacher Retirement System Of Texas | 14k | $123k | -17% | Dec 2023 |
|
Oracle Alpha | 13k | $118k | 100% | Dec 2023 |
|
Brevan Howard Capital Management | 12k | $112k | 100% | Dec 2023 |
|
Virtus ETF Advisers | 12k | $104k | 42% | Dec 2023 |
|
CI Private Wealth | 11k | $102k | -7% | Dec 2023 |
|
DLK Investment Management | 11k | $283k | 0% | Mar 2024 |
|
Simplex Trading | 11k | $280k | 100% | Mar 2024 |
|
Daiwa Securities Group | 11k | $95k | 43% | Dec 2023 |
|
E Fund Management | 11k | $95k | -38% | Dec 2023 |
|
China Universal Asset Management | 8.6k | $78k | 352% | Dec 2023 |
|
Summit Investment Advisors | 7.0k | $64k | 0% | Dec 2023 |
|
Metropolitan Life Insurance Company | 3.9k | $35k | 0% | Dec 2023 |
|
Quadrant Capital | 3.3k | $30k | 457% | Dec 2023 |
|
NISA Investment Advisors | 3.2k | $29k | 15900% | Dec 2023 |
|
Itau Unibanco Holding | 3.0k | $27k | 28% | Dec 2023 |
|
nVerses Capital | 2.7k | $69k | 100% | Mar 2024 |
|
Amalgamated Bank | 2.5k | $64k | -59% | Mar 2024 |
|
GAMMA Investing | 1.9k | $48k | 7% | Mar 2024 |
|
National Bank Of Canada /fi/ | 1.5k | $14k | 100% | Dec 2023 |
|
Quarry | 1.5k | $14k | -50% | Dec 2023 |
|
Signature | 1.5k | $13k | -16% | Dec 2023 |
|
Advisor Group Holdings | 535.00 | $4.8k | -27% | Dec 2023 |
|
Lindbrook Capital | 502.00 | $13k | 0% | Mar 2024 |
|
Wetzel Investment Advisors | 500.00 | $12k | 100% | Mar 2024 |
|
Hanson McClain Advisors | 435.00 | $11k | 0% | Mar 2024 |
|
Private Wealth Management Group | 78.00 | $706.001400 | 100% | Dec 2023 |
|
Pnc Financial Services | 36.00 | $326.001600 | 100% | Dec 2023 |
|
Glassman Wealth Services | 32.00 | $290.000000 | 23% | Dec 2023 |
|
Parallel Advisors | 17.00 | $153.999600 | -95% | Dec 2023 |
|
Covestor | 10.00 | $0 | -9% | Dec 2023 |
|
Who sold out of Avidity Biosciences Ord?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Cormorant Asset Management | Sep 2023 | 1.8M | $11M |
Franklin Resources | Sep 2023 | 344k | $2.2M |
Artal Group | Sep 2023 | 300k | $1.9M |
Baker Bros. Advisors | Sep 2023 | 166k | $1.1M |
Cubist Systematic Strategies | Sep 2023 | 156k | $996k |
Aaron Wealth Advisors | Dec 2023 | 134k | $1.2M |
Walleye Trading Advisors | Sep 2023 | 123k | $786k |
Point72 Asset Management | Sep 2023 | 61k | $387k |
Tudor Investment Corporation | Sep 2023 | 35k | $225k |
Sherbrooke Park Advisers | Sep 2023 | 17k | $107k |
Man Group | Sep 2023 | 14k | $90k |
Occudo Quantitative Strategies | Sep 2023 | 14k | $90k |
Graham Capital Management | Sep 2023 | 12k | $77k |
Aigen Investment Management | Sep 2023 | 11k | $71k |
Point72 Middle East FZE | Sep 2023 | 5.8k | $37k |
Federated Investors | Sep 2023 | 942.00 | $6.0k |
Cary Street Partner Investment Advisory | Sep 2023 | 100.00 | $638.000000 |
Authentikos Wealth Advisory | Sep 2023 | 77.00 | $490.998200 |